NOT-EB-25-001: Notice of Early Expiration of RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)"

Notice of Early Expiration of RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)"

Notice Number:

NOT-EB-25-001

Key Dates

Release Date:

April 16, 2025

Related Announcements

August 23, 2022 - RHEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed). See RFA-EB-22-002

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

Purpose

The purpose of this Notice is to alert potential applicants to the early expiration of Notice of Funding Opportunity (NOFO) RFA-EB-22-002, "HEAL Initiative: Translational Development of Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed)". Effective immediately, the final receipt date for this NOFO has been canceled. No further applications will be accepted for consideration under this NOFO.

Inquiries

Please direct all inquiries to:

Moria Bittmann, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-7699
Email: moria.bittmann@nih.gov